✦ LIBER ✦

FDA guidelines for clinical evaluation of drugs for rheumatic diseases: request for comments

✍ Scribed by Harold E. Paulus

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 134 KB
Volume: 27
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780271213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA Arthritis advisory committee meeting

FDA Arthritis advisory committee meeting: guidelines for clinical evaluation of therapies for scleroderma

✍ Harold E. Paulus 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

Fda draft guidelines for the clinical ev

Fda draft guidelines for the clinical evaluation of antiinflammatory and antirheumatic drugs in children

✍ Edward H. Giannini; Daniel J. Lovell; Bonnie Hepburn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

FDA arthritis advisory committee meeting

FDA arthritis advisory committee meeting: Methotrexate; Guidelines for the clinical evaluation of antiinflammatory drugs; DMSO in scleroderma

✍ Harold E. Paulus 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

Announcement of preliminary guidelines f

Announcement of preliminary guidelines for the management of rheumatic diseases

📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

We need simple guidelines for reporting

We need simple guidelines for reporting rates of rheumatic diseases

✍ Daniel J. McCarty; C. Kent Kwoh; Rosalind Ramsey-Goldman; Susan Manzi; Thomas A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

A cautionary approach to clinical guidel

A cautionary approach to clinical guidelines: Comment on the guidelines for monitoring drug therapy in rheumatoid arthritis

✍ A. S. Russell; W. P. Maksymowych 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views